Top Menu

SPOTLIGHT: Gardasil wins priority review

The FDA is giving a priority review to Merck's request to expand the use of Gardasil to protect against cervical cancer in women up to the age of 45. The vaccine is currently approved for girls aged 9 to 26. Report